HAP Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Sell |
9,483
-12,784
| -57% | -$1.93M | 0.1% | 131 |
|
|
2025
Q2 | $3.11M | Buy |
+22,267
| New | +$3.12M | 0.29% | 56 |
|
|
2024
Q2 | – | Sell |
-5,319
| Closed | -$721K | – | 680 |
|
|
2024
Q1 | $721K | Buy |
+5,319
| New | +$704K | 0.08% | 151 |
|
|
2023
Q2 | – | Sell |
-11,760
| Closed | -$1.63M | – | 1102 |
|
|
2023
Q1 | $1.63M | Sell |
11,760
-70,203
| -86% | -$9.45M | 0.26% | 92 |
|
|
2022
Q4 | $11.1M | Buy |
81,963
+32,131
| +64% | +$4.03M | 1.14% | 11 |
|
|
2022
Q3 | $5.47M | Sell |
49,832
-17,756
| -26% | -$2.25M | 0.37% | 65 |
|
|
2022
Q2 | $8.93M | Buy |
67,588
+50,924
| +306% | +$6.68M | 0.45% | 46 |
|
|
2022
Q1 | $2.21M | Sell |
16,664
-56,879
| -77% | -$6.82M | 0.09% | 191 |
|
|
2021
Q4 | $8.57M | Buy |
73,543
+7,684
| +12% | +$904K | 0.23% | 71 |
|
|
2021
Q3 | $7.91M | Sell |
65,859
-1,818
| -3% | -$212K | 0.26% | 85 |
|
|
2021
Q2 | $8.11M | Buy |
67,677
+51,649
| +322% | +$5.67M | 0.25% | 78 |
|
|
2021
Q1 | $1.59M | Sell |
16,028
-211
| -1% | -$21.2K | 0.09% | 221 |
|
|
2020
Q4 | $1.62M | Buy |
16,239
+441
| +3% | +$46.7K | 0.05% | 308 |
|
|
2020
Q3 | $1.73M | Sell |
15,798
-921
| -6% | -$102K | 0.09% | 177 |
|
|
2020
Q2 | $1.77M | Buy |
+16,719
| New | +$1.73M | 0.1% | 184 |
|
|
2019
Q3 | – | Sell |
-12,089
| Closed | -$1.05M | – | 1225 |
|
|
2019
Q2 | $998K | Buy |
12,089
+3,145
| +35% | +$247K | 0.08% | 215 |
|
|
2019
Q1 | $723K | Buy |
+8,944
| New | +$705K | 0.06% | 228 |
|
|
2018
Q2 | – | Sell |
-24,625
| Closed | -$1.77M | – | 979 |
|
|
2018
Q1 | $1.72M | Buy |
24,625
+15,312
| +164% | +$1.06M | 0.09% | 158 |
|
|
2017
Q4 | $646K | Buy |
+9,313
| New | +$628K | 0.03% | 348 |
|
|
2017
Q3 | – | Sell |
-111,702
| Closed | -$7.06M | – | 891 |
|
|
2017
Q2 | $7.62M | Sell |
111,702
-190,383
| -63% | -$12.4M | 0.41% | 57 |
|
|
2017
Q1 | $18.8M | Buy |
302,085
+74,266
| +33% | +$4.32M | 1.16% | 15 |
|
|
2016
Q4 | $12.4M | Buy |
+227,819
| New | +$12.9M | 0.62% | 33 |
|
|
2015
Q1 | – | Sell |
-42,487
| Closed | -$2.99M | – | 930 |
|
|
2014
Q4 | $2.99M | Sell |
42,487
-55,300
| -57% | -$3.96M | 0.11% | 154 |
|
|
2014
Q3 | $6.99M | Buy |
97,787
+76,252
| +354% | +$5.58M | 0.28% | 71 |
|
|
2014
Q2 | $1.6M | Buy |
+21,535
| New | +$1.56M | 0.06% | 239 |
|
|
2014
Q1 | – | Sell |
-12,900
| Closed | -$766K | – | 1007 |
|
|
2013
Q4 | $766K | Buy |
+12,900
| New | +$701K | 0.02% | 499 |
|
|
2013
Q3 | – | Sell |
-200,393
| Closed | -$9.48M | – | 723 |
|
|
2013
Q2 | $9.48M | Buy |
+200,393
| New | +$10.2M | 0.32% | 67 |
|
Other funds holding AZN
HAP Trading's AZN Position: Q3 2025 in Review
HAP Trading reduced its AstraZeneca (AZN) stake by 57% in Q3 2025, selling an estimated $1.93M and leaving 9,483 shares worth $1.45M. The position accounts for 0.1% of the portfolio, ranked #131.
HAP Trading first reported a position in AZN in Q2 2013 and has held it in 27 quarters since. The position peaked at $18.8M in Q1 2017. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.
- HAP Trading held 9,483 shares of AstraZeneca worth $1.45M as of Q3 2025.
- HAP Trading sold 12,784 AstraZeneca shares in Q3 2025, an estimated $1.93M.
- AstraZeneca made up 0.1% of HAP Trading's portfolio in Q3 2025, its #131 holding.
- HAP Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 27 quarters since.
- HAP Trading's AstraZeneca position peaked at $18.8M in Q1 2017.
- 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.